• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, April 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

PharmSci 360: Monday’s program highlights

Bioengineer by Bioengineer
November 5, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Highlights from Monday, Nov. 5 program include:

9:30 a.m. – 10:30 a.m.

  • A New Immunoaffinity Extraction Method for Rapid Diagnosis of Paralytic Shellfish Poisoning in Humans
    Bioanalytics, Poster Forum 4
  • Development and Characterization of an Antibiotic-Eluting Bone Void Filling (ABVF) Putty for Osteomyelitis Treatment
    Formulation and Quality, Poster Forum 8

10:30 a.m. – 11:30 a.m.

  • Elucidating the Two-Step Targeting Mechanism of Polymer Lipid Hybrid Nanoparticles for Shuttling Trastuzumab across the Blood Brain Barrier to Treat Brain Metastasis of HER2-Positive Breast Cancer
    Manufacturing and Bioprocessing, Poster Forum 6

12:30 p.m. – 1:30 p.m.

  • Optimization of Penfluridol for Use in Lung Cancer Therapy
    Preclinical Development, Poster Forum 1
  • Development and Validation of a PBPK Model to Predict Plasma and Sputum Exposures after IV, Oral or Inhalation Administration of Ciprofloxacin in Healthy Volunteers and Cystic Fibrosis Patients
    Clinical Pharmacology, Poster Forum 5

1:30 p.m. – 2:30 p.m.

  • Candidate Selection or Preclinical Evaluation of ADC and Immunotherapy Combination
    Shyra Gardai, Ph.D., Director, Head of Immunology, Seattle Genetics
    Room 207 A
  • Engineering First Principles Applications to Pharmaceutical Manufacturing
    Bernard McGarvey, Ph.D., Retired Engineering Fellow, Eli Lilly and Company
    Ballroom B
  • FDA Perspective on Development of Drug-Device Combination Products
    Ashley Boam, Director, Office of Policy for Pharmaceutical Quality, FDA/CDER/OPQ
    Ballroom C
  • The Evolution of Modeling & Simulation in Drug Development and Regulatory Applications
    Malcolm Rowland, Ph.D., DSc, Professor Emeritus, University of Manchester
    Ballroom A
  • The Expanding Frontier of Bioanalysis: New Modalities
    Binodh DeSilva, Ph.D., Vice President, Bristol-Myers Squibb
    Room 207 B

###

About AAPS:

The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 9,000 members employed in academia, industry, government, and other research institutes worldwide. Founded in 1986, AAPS advances the capacity of pharmaceutical scientists to develop products and therapies that improve global health. Visit http://www.aaps.org and follow us on LinkedIn, Facebook and Twitter @AAPSComms. The official Twitter hashtags for AAPS are: #AAPS2018 and #PharmSci360.

Media Contact

Stacey May
[email protected]
703-459-7677
@AAPSComms

http://www.aaps.org

https://www.aaps.org/aaps/pharmsci/aboutps360

Share12Tweet8Share2ShareShareShare2

Related Posts

Intrinsic Capacity, Activity Linked to Heart Risk in Elders

April 25, 2026

New Trial Prevents Cognitive Decline in Older Cancer Patients

April 25, 2026

In Vivo CAR-Neutrophils Developed for Glioma Treatment

April 25, 2026

PE/PPE Proteins Drive Tuberculosis Drug Resistance

April 25, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    820 shares
    Share 328 Tweet 205
  • New Study Reveals Plants Can Detect the Sound of Rain

    678 shares
    Share 271 Tweet 169
  • Scientists Investigate Possible Connection Between COVID-19 and Increased Lung Cancer Risk

    66 shares
    Share 26 Tweet 17
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Diazoboranes React with Oxygen to Form Dioxaboriranes

Intrinsic Capacity, Activity Linked to Heart Risk in Elders

Platelet-to-HDL Ratio Linked to Eosinophils in Pediatric Asthma

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 81 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.